The Food and Drug Administration (FDA) has approved Yeztugo ® (lenacapavir) for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at ...

LGBTQ+ youth, especially transgender youth, are at higher risk. A 2024 CDC study found that 26% of transgender and gender-questioning students had attempted suicide in the past year, compared to 5% of ...

Background. Most competitive sports segregate male and female athletes due to biologic differences between the sexes. Because exposure to testosterone in males leads to physiologic advantages in ...